Upgrade to SI Premium - Free Trial

BioAtla (BCAB)

3.44 +0.05 (1.47%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/7/26 *Est.)

Latest Headlines

Form 8-K BioAtla, Inc. For: Jul 16 July 16, 2026 4:12 PM - SEC Filing Form 4 BioAtla, Inc. For: Mar 11 Filed by: Vasquez Christian June 5, 2026 4:31 PM - SEC Filing Form 4 BioAtla, Inc. For: Mar 11 Filed by: Sievers Eric June 5, 2026 4:30 PM - SEC Filing Form 4 BioAtla, Inc. For: Mar 12 Filed by: SHORT JAY M PHD June 5, 2026 4:30 PM - SEC Filing Form ARS BioAtla, Inc. For: Dec 31 June 3, 2026 4:10 PM - SEC Filing Form DEFA14A BioAtla, Inc. June 3, 2026 4:09 PM - SEC Filing Form DEF 14A BioAtla, Inc. For: Jun 03 June 3, 2026 4:07 PM - SEC Filing Context Therapeutics amends BioAtla license deal for CT-202 drug May 18, 2026 6:45 AM - StreetInsider Context Therapeutics Enters into License Agreement Amendment with BioAtla for CT-202 May 18, 2026 6:45 AM - Globe NewsWire Form 10-Q BioAtla, Inc. For: Mar 31 May 15, 2026 4:10 PM - SEC Filing Form 10-K/A BioAtla, Inc. For: Dec 31 April 29, 2026 4:07 PM - SEC Filing Full Article List